All Stories

  1. Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study

    Article • Thrombosis Research, August 2014, Elsevier

    Dr Anders Själander

  2. Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome?

    Article • Journal of Clinical Oncology, July 2014, American Society of Clinical Oncology (ASCO)

    Dr Anders Själander

  3. Mechanical heart valve prosthesis and warfarin – Treatment quality and prognosis

    Article • Thrombosis Research, May 2014, Elsevier

    Dr Anders Själander

  4. Atrial fibrillation patients do not benefit from acetylsalicylic acid

    Article • EP Europace, October 2013, European Society of Cardiology

    Dr Anders Själander, Professor Leif Friberg

  5. Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

    Article • Blood, July 2013, American Society of Hematology

    Dr Anders Själander

  6. Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin

    Article • Thrombosis Research, June 2013, Elsevier

    Dr Anders Själander

  7. Computer aided warfarin dosing in the Swedish national quality registry AuriculA – Algorithmic suggestions are performing better than manually changed doses

    Article • Thrombosis Research, February 2013, Elsevier

    Dr Anders Själander

  8. Computerised assistance for warfarin dosage — Effects on treatment quality

    Article • European Journal of Internal Medicine, December 2012, Elsevier

    Dr Anders Själander

  9. Low-molecular-weight heparin prophylaxis does not affect mortality in acutely ill medical patients at low risk for venous thromboembolism

    Article • Evidence-Based Medicine, April 2012, BMJ

    Dr Anders Själander

  10. Combination of pegylated IFN- 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

    Article • Blood, June 2011, American Society of Hematology

    Dr Anders Själander

  11. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

    Article • European Heart Journal, May 2011, European Society of Cardiology

    Dr Anders Själander

  12. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta‐analysis

    Article • Journal of Internal Medicine, December 2007, Wiley

    Dr Anders Själander

  13. Menorrhagia and minor bleeding symptoms in women on oral anticoagulation

    Article • Journal of Thrombosis and Thrombolysis, January 2007, Springer Science + Business Media

    Dr Anders Själander

  14. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics

    Article • Scandinavian Journal of Primary Health Care, January 2007, Taylor & Francis

    Dr Anders Själander

  15. Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population

    Article • Journal of Internal Medicine, October 2003, Wiley

    Dr Anders Själander

  16. p 53 polymorphisms and haplotypes in breast cancer

    Article • Carcinogenesis, January 1996, Oxford University Press (OUP)

    Dr Anders Själander

  17. P53 polymorphisms and haplotypes in lung cancer

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Anders Själander

  18. P53 germ line haplotypes associated with increased risk for colorectal cancer

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Anders Själander

  19. The D90A mutation results in a polymorphism of Cu, Zn superoxide dismutase that is prevalent in northern Sweden and Finland

    Article • Human Molecular Genetics, January 1995, Oxford University Press (OUP)

    Dr Anders Själander